Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets. We operate primarily under a business to business (B2B) model and have an excellent track record in the development, manufacturing and marketing of complex injectables. This presence across the value chain has helped us witness exponential growth. We are promoted by Shanghai Fosun Pharma, a global pharmaceutical major.
With our proven performance in complex injectables across development, manufacturing and marketing, we are sufficiently enabled to meet diverse injectable needs across a vast range of specific requirements. Our 22 production lines for finished formulations across four facilities are complimented by three facilities for Active Pharmaceutical Ingredients (API). Plans are underway to augment the present manufacturing capacity of approximately 750 million units in the medium term to support future growth.
The ability to provide therapeutic medicines on the best quality parameters and at the right price, is the overriding objective for us at Gland Pharma. All other factors remaining equal, backward integration and economies of scale play a significant role in providing quality medications at the right price. Over the years, we have been able to move ahead on both those counts, to establish a presence across the entire value chain in Injectables.
A manufacturing base with installed capacity of 750 million units per annum spread over seven facilities; proven Research and Development wing; pan-India and global distribution and sales network; affiliation with national and state level healthcare institutions; compliance with all necessary regulatory boards; and a high level of approvals and pending filings in our area of operations, all contribute to our standing in the pharma domain.
Our family of investors and other stakeholders are the driving force that gives us a sharp focus on good governance in all our areas of operations and services. And by doing so, we are reiterating our firm resolve to deliver value and satisfaction.
Our CSR programs are broadly divided into the categories of Health and wellness, Environmental Sustainability, Education. As an example, in partnership with the Akshaya Patra Foundation, our flagship CSR programme sponsors free and healthy breakfast to over 9100 students from 66 government-run schools. The inaugural phase of this scheme will be up to April 2022. The Foundation has also provided teaching staff; and funds for construction of infrastructure in government schools. Apart from education, some government schools in our neighborhood have been adopted and provided with much-needed infrastructure like classrooms, toilets, drinking water facilities, and kitchens.
We also run a pilot ‘community cattle center‘ in Telangana, with centralized nurturing and medical facilities for the cattle. The scope of the center includes processing of animal dung into manure and vermi-compost.
For Empowerment of Rural Women, we have distributed sewing machines; and, constructed old age and orphanage homes.
Plans are on the anvil for comprehensive health plans for Socio-Economically Challenged Children; eye check-up including surgeries and more.
In the wake of Covid-19, we have contributed to various relief funds, distributed grocery stocks, cooked meals, sanitizers, masks, etc. We will also endeavor to help schools opt for online classes with infrastructure such as computers, video cameras, etc.
From the very early onset of this global pandemic, we at Gland Pharma had put in place adequate safeguards to ensure health and safety of our employees. At our facilities we have ensured un-interrupted supply and distribution of essential products.
As far as precautionary and safety measures are concerned, buses were sanitized before employees boarded and after they alighted. Each seat had only one employee. We follow an ongoing regimen of Temperature Screening / Thermal Scanning stations at the entry gate and mandatory hand washing for all employees.
Workplace fumigation and sanitization of common areas, surfaces etc., takes place every few hours. Sanitizers are placed in all departments. In house manufacturing of high-quality sanitizers and their distribution for personal use to employees is being carried out, as is weekly supply of N95 masks to all employees.
Other precautionary measures pertaining to care and distancing include: Queues with distance maintaining marker points wherever there is a line up, distance seating at canteen and other meeting places outdoor meetings.
At the workplace, staff maintains appropriate distance during Labelling Activities, Optical inspection and all other processes of manufacturing, instructions on procedures are continuously announced on PA system and through videos.
Other Corona virus awareness and safeguard tools include posters, digital displays, staggered manpower hours, employee rotations, work from home for support teams.